0001654954-20-005213.txt : 20200512 0001654954-20-005213.hdr.sgml : 20200512 20200512113110 ACCESSION NUMBER: 0001654954-20-005213 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200512 DATE AS OF CHANGE: 20200512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VASO Corp CENTRAL INDEX KEY: 0000839087 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 112871434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-18105 FILM NUMBER: 20867698 BUSINESS ADDRESS: STREET 1: 137 COMMERCIAL STREET, STE. 200 CITY: PLAINVIEW STATE: NY ZIP: 11803 BUSINESS PHONE: 516-997-4600 MAIL ADDRESS: STREET 1: 137 COMMERCIAL STREET, STE. 200 CITY: PLAINVIEW STATE: NY ZIP: 11803 FORMER COMPANY: FORMER CONFORMED NAME: VASOMEDICAL, INC DATE OF NAME CHANGE: 20120606 FORMER COMPANY: FORMER CONFORMED NAME: VASOMEDICAL INC DATE OF NAME CHANGE: 19950517 FORMER COMPANY: FORMER CONFORMED NAME: FUTURE MEDICAL PRODUCTS INC /DE/ DATE OF NAME CHANGE: 19920703 10-K/A 1 vaso_10ka.htm 10-K/A vaso_10ka
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 10-K/A
(Amendment No. 1)
 
[X] 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2019
[ ] 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Commission File No. 0-18105
 
VASO CORPORATION
(Exact name of registrant as specified in Its Charter) 
 
 Delaware
 
 11-2871434
 (State or other jurisdiction of incorporation or organization)
 
 (IRS Employer Identification Number)
 
137 Commercial St., Suite 200, Plainview, New York 11803
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: (516) 997-4600
 
Securities registered under Section 12(b) of the Act: None
Title of each class
Trading Symbol
Name of each exchange on which registered
 
 
 
 
Securities registered under Section 12(g) of the Act:
Common Stock, $.001 par value
(Title of Class)
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [ X ]
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [ X ]
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X ]  No [ ]
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) Yes [ X] No [ ]
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [X] Smaller reporting company [X] Emerging growth company [ ]
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [ X ]
 
The aggregate market value of common stock held by non-affiliates was approximately $3.0 million based on the closing sales price of the common stock as quoted on the OTC PK on June 28, 2019.
 
At April 9, 2020, the number of shares outstanding of the issuer's common stock was 174,436,289.

 
 
 
EXPLANATORY NOTE
 
Vaso Corporation (the "Company") is filing this amendment (the "Amendment") to its Annual Report on Form 10-K filed on April 14, 2020 (the "Original Form 10-K") solely to disclose that the Company had filed the Original Form 10-K after the March 30, 2020 deadline applicable to the Company for the filing of a Form 10-K in reliance on the 45-day extension provided by an order issued by the Securities and Exchange Commission (the "SEC") pursuant to Section 36 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (Release Nos. 34-88318 dated March 4, 2020 and Release Nos. 34-88465 dated March 25, 2020) (the "Order"). 
 
On March 30, 2020, the Company filed a Current Report on Form 8-K to indicate its intention to rely on the Order for such extension. Consistent with the Company's statements made in the Form 8-K, the Company was unable to file the Original Form 10-K prior to the prescribed March 30, 2020 filing date because the Company' s operations and business have experienced significant disruptions due to the new coronavirus ("COVID-19") pandemic. More specifically, both the Company and its auditors were experiencing staffing difficulties materially impairing its ability to file on the prescribed date. The Company’s principal offices, including its accounting department, are located in Nassau County, New York, which area has been significantly impacted by COVID-19.
 
As required by Rule 12b-15 under the Exchange Act, the Company is including in this Amendment certifications from its Principal Executive Officer and Principal Financial Officer as required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act as exhibits to this Amendment. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. We are not including the certifications under Section 906 of the Sarbanes-Oxley Act of 2002 as no financial statements are being filed with this Amendment.
 
Except as described above, this Amendment does not modify or update disclosures in, or exhibits to, the Original Form 10-K. Furthermore, this Amendment does not change any previously reported financial results nor does it reflect events occurring after the filing of the Original Form 10-K. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and the Company's filings with the SEC subsequent to the filing of the Original Form 10-K.
 
 
 
PART IV
 
ITEM 15 – EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
 
Exhibits
 
 
Certification reports pursuant to Securities Exchange Act Rule 13a/15d
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 12th day of May, 2020.
 
 
 
VASO CORPORATION
 
 
 
 
 
 
By:  
/s/ Jun Ma
 
 
 
Jun Ma 
 
 
 
President and Chief Executive Officer 
and Director (Principal Executive Officer)
 
 
 
 

 
EX-31.1 2 vaso_ex311.htm CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 vaso_ex311
 
EXHIBIT 31.1
 
CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Jun Ma, certify that:
 
1.
I have reviewed this report on Form 10-K/A of Vaso Corporation and subsidiaries (the “registrant”);
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
 
 
/s/ Jun Ma .
Jun Ma
President and Chief Executive Officer
Dated: May 12, 2020
 
 
EX-31.2 3 vaso_ex312.htm CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 vaso_ex312
 
EXHIBIT 31.2
 
CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Michael Beecher, certify that:
 
1.
I have reviewed this report on Form 10-K/A of Vaso Corporation and subsidiaries (the “registrant”);
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
 
/s/ Michael Beecher
Michael Beecher
Chief Financial Officer
Dated: May 12, 2020
 
 
GRAPHIC 4 vaso_10k000.jpg IMAGE begin 644 vaso_10k000.jpg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end